The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children ...

Products like novolog, novomix, and novorapid are contributing significantly to diabetes management by providing rapid-acting insulin for quick blood sugar reduction and, in the case of novomix ...

A chronic medical condition, diabetes results in the body's inability to produce enough insulin or use it effectively, leading to high blood sugar levels. Interestingly, Novolog Mix 70 or 30 ...

NovoLog FlexPen; and NovoLog PenFill. According to HHS, these drugs accounted for $50.5 billion in total Part D gross covered prescription drug costs between June 1, 2022, and May 31, 2023. 2 “The ...

Medicare has undergone several major changes since it launched in 1965. And now, with the passage of the Inflation Reduction Act of 2022, it's poised to change again, with several key ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. Insulin prices averaged 19 cents per unit as ...

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over unaffordable prices that led several ...

Earlier this month, non-profit drugmaker Civica Rx pledged to launch biosimilars of three big-selling insulin products in the US – Sanofi's Lantus, Novo Nordisk's Novolog and Eli Lilly's Humalog ...